- Home
- LUCD vs CCIF Comparison
LUCD vs CCIF Comparison
Compare LUCD & CCIF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LUCD
- CCIF
- Stock Information
- Founded
- LUCD 2018
- CCIF 2011
- Country
- LUCD United States
- CCIF United States
- Employees
- LUCD N/A
- CCIF N/A
- Industry
- LUCD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- CCIF Finance/Investors Services
- Sector
- LUCD Health Care
- CCIF Finance
- Exchange
- LUCD Nasdaq
- CCIF Nasdaq
- Market Cap
- LUCD 108.0M
- CCIF 121.4M
- IPO Year
- LUCD 2021
- CCIF N/A
- Fundamental
- Price
- LUCD $1.08
- CCIF $5.72
- Analyst Decision
- LUCD Strong Buy
- CCIF
- Analyst Count
- LUCD 5
- CCIF 0
- Target Price
- LUCD $3.65
- CCIF N/A
- AVG Volume (30 Days)
- LUCD 1.7M
- CCIF 76.9K
- Earning Date
- LUCD 11-12-2025
- CCIF 01-01-0001
- Dividend Yield
- LUCD N/A
- CCIF 25.90%
- EPS Growth
- LUCD N/A
- CCIF N/A
- EPS
- LUCD N/A
- CCIF N/A
- Revenue
- LUCD $4,360,000.00
- CCIF N/A
- Revenue This Year
- LUCD $13.90
- CCIF N/A
- Revenue Next Year
- LUCD $163.88
- CCIF N/A
- P/E Ratio
- LUCD N/A
- CCIF N/A
- Revenue Growth
- LUCD 14.74
- CCIF N/A
- 52 Week Low
- LUCD $0.73
- CCIF $7.43
- 52 Week High
- LUCD $1.80
- CCIF $10.16
- Technical
- Relative Strength Index (RSI)
- LUCD 46.78
- CCIF 49.02
- Support Level
- LUCD $1.05
- CCIF $5.62
- Resistance Level
- LUCD $1.10
- CCIF $5.91
- Average True Range (ATR)
- LUCD 0.09
- CCIF 0.12
- MACD
- LUCD -0.02
- CCIF 0.01
- Stochastic Oscillator
- LUCD 14.15
- CCIF 54.68
About LUCD Lucid Diagnostics Inc.
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.
About CCIF Carlyle Credit Income Fund Shares of Beneficial Interest
Carlyle Credit Income Fund is a non-diversified, closed-end management investment company. The Fund's primary investment objective is to generate current income, with a secondary objective to generate capital appreciation. The Fund seeks to achieve its investment objective by investing predominantly in equity and junior debt tranches of collateralized loan obligations, that are collateralized by a portfolio consisting mainly of below-investment-grade U.S. senior secured loans with a large number of distinct underlying borrowers across various industry sectors.